MediciNova, Inc. (MNOV) Earnings History
Net Loss23 years of earnings data (2003–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
MediciNova, Inc. (MNOV) Earnings Overview
As of June 28, 2026, MediciNova, Inc. (MNOV) reported trailing twelve-month net income of -$12M, reflecting -4.3% year-over-year growth. The company earned $-0.24 per diluted share over the past four quarters, with a net profit margin of -2928.8%.
Looking at the long-term picture, MNOV's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2013.
MediciNova, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SIGA ($20M net income, 24.6% margin), NRXP (-$25M net income, -2336.5% margin), AVXL (-$40M net income), MNOV has room to improve margins relative to the peer group. Compare MNOV vs SIGA →
MNOV Earnings vs Peers
Earnings metrics vs comparable public companies
MNOV Historical Earnings Data (2003–2025)
23 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$12M | -8.6% | -$13M | $-0.24 | -2928.8% | -3242.5% |
| 2024 | -$11M | -28.9% | -$13M | $-0.23 | - | - |
| 2023 | -$9M | +39.1% | -$10M | $-0.17 | -857.2% | -990.0% |
| 2022 | -$14M | -38.8% | -$15M | $-0.29 | - | - |
| 2021 | -$10M | +26.8% | -$10M | $-0.21 | -251.0% | -253.0% |
| 2020 | -$14M | -7.0% | -$14M | $-0.31 | - | - |
| 2019 | -$13M | +11.8% | -$14M | $-0.30 | - | - |
| 2018 | -$15M | -31.5% | -$16M | $-0.36 | - | - |
| 2017 | -$11M | -2.7% | -$13M | $-0.32 | - | - |
| 2016 | -$11M | -22.8% | -$11M | $-0.33 | - | - |
| 2015 | -$9M | +3.8% | -$9M | $-0.33 | - | - |
| 2014 | -$9M | -128.3% | -$9M | $-0.38 | - | - |
| 2013 | -$4M | +63.2% | -$4M | $-0.19 | -67.1% | -67.0% |
| 2012 | -$11M | +38.2% | -$11M | $-0.64 | -1365.8% | -1363.8% |
| 2011 | -$18M | +12.2% | -$16M | $-1.20 | - | - |
| 2010 | -$20M | +0.9% | -$18M | $-1.63 | - | - |
| 2009 | -$20M | +7.1% | -$21M | $-1.68 | - | - |
| 2008 | -$22M | +55.2% | -$23M | $-1.82 | - | - |
| 2007 | -$49M | -37.0% | -$53M | $-4.16 | -18.5% | -20.3% |
| 2006 | -$36M | -38.9% | -$42M | $-3.52 | -13525.1% | -15794.3% |
| 2005 | -$26M | +46.8% | -$30M | $-2.88 | -3195.3% | -3741.9% |
| 2004 | -$48M | -677.4% | -$49M | $-965.45 | -9845.9% | -9915.2% |
| 2003 | -$6M | - | -$6M | $-124.18 | - | - |
Download Data
Export MNOV earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
23+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MNOV — Frequently Asked Questions
Quick answers to the most common questions about buying MNOV stock.
What is MNOV earnings per share (EPS)?
MNOV trailing twelve-month (TTM) diluted EPS is $-0.24, reflecting -4.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2003 to 2025 is available in the table on this page.
What is MediciNova, Inc.'s net income?
MediciNova, Inc. (MNOV) trailing twelve-month net income is $-12M as of 2025. Earnings declined -4.3% year-over-year.
Is MNOV profitable?
MNOV is not currently profitable on a TTM basis, reporting a net loss of $-12M. Net margin is -2928.8%. Investors should monitor for a return to profitability.
What is MNOV's earnings growth rate?
MNOV compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2003 to 2025.
What are MNOV's profit margins?
MediciNova, Inc. net profit margin is -2928.8%, operating margin is -3242.5%, and gross margin is +7.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is -25.5%.
Is MNOV growing earnings?
MNOV earnings growth is slowing. Current YoY EPS growth of -4.3% trails the 5-year CAGR of N/A. TTM net income is $-12M.
What was MNOV's best earnings year?
MediciNova, Inc.'s highest annual net income on record is $-4M, achieved in fiscal year 2013. Earnings history on this page spans 2003 to 2025 and includes all annual and quarterly figures.
What were MNOV's earnings last quarter?
MNOV's most recent reported quarter was Q1 2026. Net income was $-3M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.